Catalyst Wire Dossier Catalyst Wire Dossier

Bupropion hydrochloride extended-release (XL)

Bupropion hydrochloride · Epic Pharma, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Bupropion hydrochloride extended-release (XL), covering 2020-06-30 to 2024-12-17. Get the full timeline:

Most recent: FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Vitruvias Therapeutics)

See pricing